Defensive Implantable Cardioverter-Defibrillator Programming Is Safe and Reduces Inappropriate Therapy　- Comparison of 3 Programming Strategies in 1,471 Patients.

BACKGROUND Careful device programming is necessary to reduce inappropriate antitachycardia pacing (ATP) and shock therapy in recipients of implantable cardioverter-defibrillators (ICD). This retrospective study investigated the safety and efficacy of a therapy-reducing programming strategy in comparison with conventional strategies in consecutive ICD recipients of a university cardiac center. Methods and Results: All 1,471 ICD recipients from 2000 to 2015 were analyzed. Individual ICD programming (IND) was used from 2000 to 2005 followed by standard-three-zone programming (STD) until 2010. From 2010 to 2015 therapy-reducing long detection time programming (RED) was established. The mean follow-up was 2.4±1.6, 2.3±1.6 and 1.7±1.2 years in the IND, STD and RED groups, respectively. Switchover from IND to STD revealed a significant reduction in inappropriate ATP (P=0.024) and shock therapy (P<0.001). Further reduction of 58% (RR=0.42, 95% confidence interval [CI]: 0.17-1.04; P=0.061) in inappropriate ATP and 29% (RR=0.71, 95% CI: 0.29-1.72; P=0.452) in inappropriate shock therapy was achieved by switchover from STD to RED. Kaplan-Meier analysis revealed a significant difference in time until first inappropriate ATP and shock therapy among the 3 groups, being lowest in the RED group (P≤0.001). There was no difference in overall mortality (P=0.416). CONCLUSIONS Defensive ICD programming with prolonged detection times is safe and significantly reduced inappropriate ICD therapies.

• Publication year

  2018

• Venue

  Circulation Journal

• Publication date

  2018-11-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.1253/circj.CJ-18-0611PMID 30270313
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Risk of arrhythmic death in ischemic heart disease: a prospective, controlled, observer‐blind risk stratification over 10 years

  2017cited by this paper
• Inappropriate shocks in single-chamber and subcutaneous implantable cardioverter-defibrillators: a systematic review and meta-analysis

  2017cited by this paper
• Extended detection time to reduce shocks is safe in secondary prevention patients: The secondary prevention substudy of PainFree SST.

  2016cited by this paper
• Results of ENHANCED Implantable Cardioverter Defibrillator Programming to Reduce Therapies and Improve Quality of Life (from the ENHANCED-ICD Study).

  2016cited by this paper
• Reduced risk for inappropriate implantable cardioverter-defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION study.

  2014cited by this paper
• Multiple Autonomic and Repolarization Investigation of Sudden Cardiac Death in Dilated Cardiomyopathy and Controls

  2014cited by this paper
• Programming Implantable Cardioverter‐Defibrillators in Patients with Primary Prevention Indication to Prolong Time to First Shock: Results from the PROVIDE Study

  2014cited by this paper
• Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial.

  2013cited by this paper
• Prognostic impact of inappropriate defibrillator shocks in a population cohort

  2013cited by this paper
• Frequency of Inappropriate Therapy in Patients Implanted with Dual‐ Versus Single‐Chamber ICD Devices in the ICD Arm of MADIT‐CRT

  2013cited by this paper
• Reduction in inappropriate therapy and mortality through ICD programming.

  2012cited by this paper
• First inappropriate implantable cardioverter defibrillator therapy is often due to inaccurate device programming: analysis of the French OPERA registry.

  2012cited by this paper
• Real World Evaluation of Dual‐Zone ICD and CRT‐D Programming Compared to Single‐Zone Programming: The ALTITUDE REDUCES Study

  2011cited by this paper
• Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality.

  2011cited by this paper
• Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.

  2008cited by this paper
• Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.

  2008cited by this paper
• Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.

  2004cited by this paper
• Primary Prevention of Sudden Cardiac Death in Idiopathic Dilated Cardiomyopathy: The Cardiomyopathy Trial (CAT)

  2002cited by this paper
• A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators.

  1999cited by this paper

• Anti-tachycardia Pacing: Mechanism, History and Contemporary Implementation

  2022cites this paper
• Comparison of burst versus ramp antitachycardia pacing therapy for ventricular tachycardia: A meta‐analysis

  2021cites this paper
• Appropriate and inappropriate therapy in patients with single- or multi-chamber implantable cardioverter-defibrillators.

  2020cites this paper
• Recommendations for driving after implantable cardioverter defibrillator implantation and the use of a wearable cardioverter defibrillator

  2020cites this paper
• Fitness to Drive After Syncope and/or in Cardiovascular Disease - An Overview and Practical Advice.

  2020cites this paper
• Elevated plasma levels of asymmetric dimethylarginine and the risk for arrhythmic death in ischemic and non-ischemic, dilated cardiomyopathy - a prospective, controlled long-term study.

  2020cites this paper
• Importance of Diastolic Function for the Prediction of Arrhythmic Death

  2020cites this paper
• Sex difference in inappropriate therapy and survival among 1471 implantable cardioverter‐defibrillator recipients

  2019cites this paper